BIOTRONIK and Egg Medical Form Strategic Alliance to Improve Radiation Protection for Interventional Healthcare Workers

BIOTRONIK, a global leader in cardiovascular, endovascular, and neuromodulation solutions, today announced it is partnering with Egg Medical, Inc., a global leader in radiation protection technology, to co-sell Egg Medical’s EggNest™ Radiation Protection Systems for healthcare workers in the United States.

The EggNest Systems (EggNest XR, EggNest Protect & EggNest Complete) are innovative radiation protection platforms that can be used across a wide variety of fluoroscopy procedure types without impacting workflow. The EggNest Systems are the only products commercially available in the US able to protect everyone in the interventional suite. Radiation reductions of up to 97% are possible with EggNest XR and EggNest Protect, and up to 99% reductions are possible with EggNest Complete.1

“Partnering with companies like Egg Medical in the radiation protection space allows BIOTRONIK to bring our vision of ‘Excellence for Life’ to healthcare professionals as well as their patients.  These products will allow us to bring a safer environment to every member of the EP lab, Cath lab, and other procedure suites,” said Matt Roberts, VP, National and Corporate Accounts at BIOTRONIK.

“We are thrilled to partner with BIOTRONIK, who has been focused on providing radiation protection to their customers for many years. This partnership expands our ability to provide protection for everyone in the procedure room across the US,” said Gavin Philipps, Chief Commercial Officer at Egg Medical.

More Articles from the Medical Industry

BIOTRONIK and Egg Medical Form Strategic Alliance to Improve Radiation Protection for Interventional Healthcare Workers

BIOTRONIK, a global leader in cardiovascular, endovascular, and neuromodulation solutions, today announced it is partnering with Egg Medical, Inc., a …

Japan Smart Healthy Aging QuickFire Challenge 2024

Overview Imagine a future where healthy aging is prioritized, and innovations drive transformative change. In Japan, the population is aging …

HUMAN Diagnostics Announces the Launch of its Next Generation Clinical Chemistry Instruments at Medlab Middle East 2025

Wiesbaden, Germany – February 1, 2025 – HUMAN Diagnostics, a global player in in vitro diagnostics, announces the launch of …

Ireland’s Healthcare Pioneers Set to Transform Middle East Healthcare at Arab Health 2025

19 Irish companies, supported by Enterprise Ireland, to present cutting-edge medtech and digital healthcare solutions at Arab Health 2025. Major …
Share via
Copy link